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Abstract
Oropharyngeal candidiasis is an opportunistic infection considered to be a harbinger of AIDS. The etiologic agent Candida
albicans is a fungal species commonly colonizing human mucosal surfaces. However, under conditions of immune
dysfunction, colonizing C. albicans can become an opportunistic pathogen causing superficial or even life-threatening
infections. The reasons behind this transition, however, are not clear. In the oral cavity, salivary antimicrobial peptides are
considered to be an important part of the host innate defense system in the prevention of microbial colonization. Histatin-5
specifically has exhibited potent activity against C. albicans. Our previous studies have shown histatin-5 levels to be
significantly reduced in the saliva of HIV+ individuals, indicating an important role for histatin-5 in keeping C. albicans in its
commensal stage. The versatility in the pathogenic potential of C. albicans is the result of its ability to adapt through the
regulation of virulence determinants, most notably of which are proteolytic enzymes (Saps), involved in tissue degradation.
In this study, we show that C. albicans cells efficiently and rapidly degrade histatin-5, resulting in loss of its anti-candidal
potency. In addition, we demonstrate that this cellular activity is due to proteolysis by a member of the secreted aspartic
proteases (Sap) family involved in C. albicans pathogenesis. Specifically, the proteolysis was attributed to Sap9, in turn
identifying histatin-5 as the first host-specific substrate for that isoenzyme. These findings demonstrate for the first time the
ability of a specific C. albicans enzyme to degrade and deactivate a host antimicrobial peptide involved in the protection of
the oral mucosa against C. albicans, thereby providing new insights into the factors directing the transition of C. albicans
from commensal to pathogen, with important clinical implications for alternative therapy. This report characterizes the first
defined mechanism behind the enhanced susceptibility of HIV+ individuals to oral candidiasis since the emergence of HIV.
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Introduction
Immunocompromised individuals and particularly the HIV-
infected constitute a population that is highly susceptible to an
array of opportunistic infections. Among the opportunistic
pathogens, the fungal species Candida albicans is perhaps the most
successful in humans [1]. A commensal fungus frequently
colonizing human mucosal surfaces, C. albicans has long been
adapted to the human host and has evolved because of the specific
demands of the human host environment. Distinctively, under
conditions of immune dysfunction, colonizing C. albicans strains
can become opportunistic pathogens causing recurrent mucosal
infections and life-threatening disseminated infections with high
mortality rates [2,3].
The association between oral candidiasis and an immunocom-
promised state dates back to the 19
th century when oral candidiasis
was recognized as ‘‘…… always the consequence of a pre-existing morbid
state.’’ This association became quite evident with the emergence
of AIDS in the early 1980s. In HIV+ individuals, oropharyngeal
candidiasis is considered an AIDS-defining illness with 80–90% of
these individuals suffering recurrent episodes during the course of
their illness [2,4,5]. The increasing emergence of strains of C.
albicans resistant to the commonly used antifungal agents has made
clinical management of candidiasis increasingly difficult and the
need for improved drug therapies crucial [2,6].
The oral cavity is a unique environment and a primary target
for opportunistic infections, particularly candidiasis [4,6]. The oral
mucosa constitutes a critical protective interface between external
and internal environments that serves as a barrier to the hundreds
of microbial species present in this environment [4,6]. In the oral
cavity, saliva, a complex mix of fluids from salivary glands plays an
important role in the maintenance of oral mucosal health [7,8].
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produced by the host which are considered to be an important
part of the innate immune system, contributing to maintaining the
balance between health and disease in this complex environment
[9,10]. Surprisingly, the important role of these natural antimi-
crobials in the protection of the oral cavity from the constant
exposure to microbial challenges and particularly their potential as
therapeutic agents, is only just beginning to be appreciated.
Most notable among the natural immune salivary antimicrobial
peptides are the histatins, a family of low-molecular-weight,
histidine-rich, cationic proteins produced and secreted by human
parotid and submandibular-sublingual glands [11–13]. Histatins
show killing activities against numerous oral bacteria, as well as
potent antifungal properties against pathogenic fungi including C.
albicans [12,14,15]. Histatin-5 (Hst-5) specifically, a 24-amino acid
member of the family, has the highest level of activity against C.
albicans including strains resistant to antifungal agents, implicating
a different mode of action than the commonly used drugs [16,17].
Histatin-5 is believed to exert its anti-candidal effect through
binding to receptor proteins (Ssa1 and Ssa2) on the fungal cell
membrane [18]. Once internalized, Hst-5 inhibits mitochondrial
respiration, thus inducing the formation of reactive oxygen species
thereby leading to mitochondrial and cytoplasmic membrane
damage, efflux of ATP and cell death [10,17,19]. Recently,
expansive investigations by Mochon et al. [20] provided direct
evidence for a breach in plasma membrane as the initial damage
by extracellular Hst-5 on C. albicans and a mechanism of its
internalization into the cytoplasm.
Although not since substantiated, studies in the early 1990s had
reported changes in salivary histatin concentrations in HIV+
individuals, the result of salivary gland dysfunction [5,21]. Given
the important role of saliva in maintaining oral health, it is
conceivable that alterations in salivary gland secretion and/or
composition are liable to contribute to the markedly enhanced
predisposition of this population to oral candidiasis. Yet studies
confirming these important observations have been lacking, most
likely due to the lack of feasible methods for measuring salivary
histatin concentrations. Recently, however, we confirmed these
observations in a study comparing the levels of salivary Hst-5
between a group of HIV+ and HIV2 individuals. Results from the
investigation demonstrated significantly lower Hst-5 levels in the
HIV+ group, concomitant with increased prevalence of C. albicans
in the oral cavity, highlighting the involvement of host innate
immunity in the protection against C. albicans colonization [22].
It is well-established that the process of development and course
of microbial infections is regarded as an encounter between the
virulence of a microorganism and the ability of the host to prevent
microbial colonization or invasion. In the case of C. albicans, the
transition from harmless commensal to disease-causing pathogen is
finely balanced and attributable to an extensive array of virulence
factors selectively expressed under suitable predisposing host
conditions. This is quite evident through the diverse manifestations
of candidiasis, for in addition to oral infections, C. albicans is
currently ranked the third most commonly isolated bloodstream
pathogen in hospitalized patients with a mortality rate of 40–50%
[2,23].
Most notable among the repertoire of virulence determinants
expressed by C. albicans are a family of 10 proteolytic enzymes
known as the secreted aspartic proteases (Saps) [24,25]. The SAP
gene family has been shown to be differentially expressed under a
variety of laboratory growth conditions and during experimental
C. albicans infections in vitro and in vivo [26–29]. The contribution of
the Saps to mucosal and systemic infections and their involvement
in adherence, tissue damage and evasion of host immune
responses was clearly demonstrated using SAP-deficient mutants
and protease inhibitors [25]. Candida albicans Saps have been
shown to degrade a variety of host defense proteins such as
lactoferrin and immunoglobulins [30]. A recent study by Villar et
al. [31] demonstrated that C. albicans is able to degrade E-cadherin,
the major protein in epithelial cell junction and that the
degradation was mediated by Sap5. Therefore, the Sap isoen-
zymes appear to have a variety of functions in vivo which are
probably called upon at different stages and in different types of C.
albicans infections [25,32].
Although the majority of the Sap enzymes are secreted by the
fungus, the most recently identified members, Sap9 and Sap10 are
cell surface glycosylphosphatidylinositol (GPI)-anchored proteases
located in the fungal cell membrane and cell wall that have been
described to be similar to the S. cerevisiae yaspin Yps1[32,33]. In
contrast to the secreted Saps (Saps1–8), no known specific host
substrate has been identified for these proteases and consequently
they were considered to target only proteins of fungal origin [32].
Precisely, because of their location and due to the fact that mutants
lacking these proteases were hypersensitive to cell surface disturbing
agents and similar to the S. cerevisiase Ysp1, the Sap9 and Sap10
proteases were linked to regulatory processes on the fungal cell
surface with functions necessary for cell surface integrity [32,33].
Despite the extensive available information on the association of
C. albicans Saps and host protein degradation, in depth
investigating into the ability of the Saps to degrade small salivary
antimicrobial peptides specifically those with potent anti-candidal
properties such as histatins, has not been fully investigated. A study
by Ruissen et al. [34] had reported the susceptibility of Hst-5 to
proteolysis by C. albicans. Although the secreted C. albicans enzymes
were not found to be the responsible for the observed proteolysis in
that study, a specific C. albicans-substance was not identified.
The identification of histatins as substrates to the Sap enzymes
and the identification of a specific C. albicans-factor the maybe
involved in evasion of host immune defenses would be of great
significance as it would implicate direct post-secretional proteolysis
of histatin in its decreased salivary levels. Such findings would
carry significant implications as they may contribute to our
understanding of the quandary of the enhanced propensity of the
HIV+ population to oral candidiasis. To that end, this study aimed
to analyze the ability of C. albicans to degrade Hst-5 in vitro and to
attribute the proteolytic activity to the secreted aspartic proteases.
Results
Degradation of Hst-5 by C. albicans
In vitro degradation assays were designed to determine whether
C. albicans possess the ability to degrade Hst-5. Following exposure
of the peptide to C. albicans whole cells and cell-free supernatants of
C. albicans cell suspensions, degradation reactions were subjected to
electrophoretic analysis. Images revealed a gradual loss of peptide
integrity proportional to the C. albicans cell density (Figure 1A and
1B) and time of exposure (Figure 2) demonstrating that C. albicans
cells efficiently and rapidly degrade Hst-5. Furthermore, using a
range of Hst-5 concentrations, the level of degradation was shown
to be inversely proportional to Hst-5 concentration (50–200 mg/
ml) (data not shown). Experiments to determine whether the
proteolytic substance is secreted by C. albicans demonstrated
significantly less degradation of Hst-5 by cell-free supernatants
compared to whole C. albicans cells (Figure 3C).
Inhibition of degradation by aspartic protease inhibitor
Proteinase K used as positive control for degradation completely
degraded Hst-5 and degradation was inhibited by the serine
Host Innate Immunity
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pepstatin A (Figure 3A). In contrast, PMSF failed to inhibit C.
albicans degradation whereas pepstatin A resulted in inhibition of
degradation indicating that the C. albicans-associated proteolytic
substance is aspartic in nature (Figure 3B).
Degradation of Hst-5 by C. albicans purified proteases
Purified proteases representing the various subfamilies of C.
albicans Saps were tested for their ability to degrade Hst-5. Results
demonstrated that Sap9 resulted in significant proteolysis of Hst-5
and to a lesser degree Sap10 protease, under all conditions tested
and that the degradation was inhibited by pepstatin A. (Figure 3D).
Sap5 protease did not degrade Hst-5 (data not shown), however
Sap2 protease extensively degraded Hst-5 (Figure S1).
Degradation of Hst-5 by C. albicans SAP mutants
To identify the Sap isoenzyme responsible for the degradation, C.
albicans SAP null mutants were tested for their ability to degrade Hst-
5.Results demonstrated nonoticeableinhibition indegradation with
the sap1–3 and sap4–6 mutants (data not shown), however, with the
mutants lacking the cell surface-anchored proteases some degree of
inhibition was seen with the sap10 mutant, whereas complete loss of
degradationwasobservedwiththesap9singleandthesap9,10double
mutants (Figure 4) compared to their parent strain (CAI4) and the C.
albicans SC5314 strain.
Peptide sequencing of degradation products by MALDI-
TOF/TOF MS analysis
In order to determine the peptide sequences of the cleaved
fragments, fragmentation products from the various degradation
reactions with C. albicans cells and purified proteases were subjected
to Mass Spectrometry. MALDI analysis revealed the presence of
four peaks corresponding to 4 fragments generated following
degradation of Hst-5 by C. albicans cells (Figure 5). The profile of
thedegradationbyC.albicans mostcloselyresembledthatoftheSap9
protease (Figure 6). Specifically a 1491.8 Dalton (m+H
+)f r a g m e n t
generated by C. albicans cleavage was present only in the reactions
with theSap9protease.Interestingly,although the Sap5protease did
not degrade Hst-5 (data not shown), the Sap2 protease extensively
degraded Hst-5 (Figure 6, Figure S1).
Killing assay
In order to determine the anti-candidal potency of Hst-5,
percent killing of C. albicans by Hst-5 was determined. The results
Figure 1. Degradation and killing potency of Hst-5. (A) Degradation of Hst-5 by C. albicans demonstrating degradation level proportional to
cell density (cells/ml). (B) Decrease in the percent Integrated Density Value (IDV) of the intact Hst-5 (upper band) (P,0.02) and increase in density of
degradation product (P,0.0001) (lower band). (C) Percent killing demonstrating significant killing + of C. albicans at 1610
6 cells/ml density
correlating with no degradation + at that cell density; whereas no killing* at 2610
9 cells/ml correlates with significant degradation*. Error bars
indicate the standard errors of the means.
doi:10.1371/journal.pone.0005039.g001
Host Innate Immunity
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5039from the killing assays demonstrated that the susceptibility of C.
albicans to Hst-5 was inversely proportional to its cell density. At C.
albicans density unable to significantly degrade Hst-5 (Figure 1A),
.90% (p,0.05) of the cells were killed by Hst-5 (Figure 1C).
Conversely, higher C. albicans cell densities shown to degrade Hst-5
(Figure 1A), were significantly less susceptible to killing by Hst-5
(Figure 1C).
More importantly, the location of cleavage sites for C. albicans
and Sap9 within the antimicrobial fragment of Hst-5 as identified
by peptide sequencing, implied that cleavage at these residues may
affect the anti-candidal properties of Hst-5 (Figure 6). In order to
validate the hypothesis, killing assays were performed to compare
the potency of Hst-5 pre- and post-degradation by C. albicans cells
and purified proteases.
Killing assays with the fragmented Hst-5 fragmented by C.
albicans demonstrated 0% (p,0.05) killing ability compared to
.90% prior to its cleavage. Similarly, degradation of Hst-5 by
Sap9 and Sap10 purified proteases resulted in complete loss of
Hst-5 killing ability.
Conversely, assays with Hst-5 following exposure to the sap9,10
mutants did not affect its killing ability (p,0.05) corroborating the
inability of these mutants to degrade Hst-5 thus preserving its
killing potency as represented in Figure 3C.
Similarly, degradation reactions where pepstatin A was
incorporated, not only salvaged Hst-5 from degradation by C.
albicans but also maintained its ability to kill C. albicans (p,0.05).
Combined, these findings directly associated the proteolysis of Hst-
5b yC. albicans and purified proteases to loss of its killing activity
and its preservation from degradation with conservation of its anti-
candidal ability.
Discussion
Candida albicans is a commensal fungus commonly colonizing
human mucosal surfaces. However, under conditions of immune
dysfunction, colonizing C. albicans c a nb e c o m ea no p p o r t u n i s t i c
pathogen causing recurrent infections [2,4]. The versatility in
the pathogenic potential of this fungal species is the result of its
ability to adapt, evolve and evade host immune defenses
through the regulation of virulence determinants, selectively
expressed under suitable predisposing conditions [35–37].
These virulence factors may well vary, depending on the type
of infection, the stage and site of infection and the nature of the
host response. Most notable among the pathogenic features of C.
albicans are the secreted aspartic proteases, a family of
proteolytic enzymes considered to be vital for its pathogenesis
[24,25,32].
The oral cavity is a prime target for infection by C. albicans.A sa
salivary peptide with potent anti-candidal properties, Hst-5 has
been proposed to play an important role in protecting the oral
mucosa from over-colonization by commensal C. albicans strains.
Our previous investigations have demonstrated that HIV+
individuals, the population most vulnerable to oral candidiasis,
have significantly decreased levels of Hst-5 in their saliva,
concomitant with increased colonization with C. albicans [22].
These observations strongly supported the notion of an involve-
ment for Hst-5 in the enhanced propensity of HIV+ individuals to
this opportunistic infection [22].
Previous studies had reported the degradation of histidine-rich
peptides by proteases. A study by Xu et al. [38] described loss of
Figure 2. Degradation of Hst-5 by C. albicans over time
(minutes) demonstrating degradation level proportional to
exposure time. (A) Minor degradation following 20 mins incubation
at 37uC observed by the appearance of lower weight product, whereas
significantly increasing level of degradation seen following 1 h and 2 h
incubation (B) Decrease in the percent of Integrated Density Value (IDV)
of the intact Hst-5 (upper band) (P,0.0001) and increase in the IDV of
the degradation product (lower band P,0.02) MW: molecular weight
ladder.
doi:10.1371/journal.pone.0005039.g002
Figure 3. Degradation of Hst-5 under various conditions and C.
albicans strains. (A) Complete degradation of Hst-5 by proteinase K
(PK) used as positive control and inhibition of degradation by PMSF but
not by pepstatin A (P) (B) Conversely, inhibition of C. albicans
degradation by pepstatin A but not by PMSF (C) Minimal degradation
observed when Hst-5 was incubated with C. albicans supernatant (CA-
sup) D) Significant degradation of Hst-5 by 0.0625 mg Sap9 and Sap10
purified proteases and inhibition of degradation by pepstatin A.
doi:10.1371/journal.pone.0005039.g003
Host Innate Immunity
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degradation by salivary protease. Similarly, Helmerhorst et al. [9]
demonstrated that oral-fluid is capable of degrading Hst-5 in vitro.
However, these studies attributed peptide degradation to intrinsic
biological properties of saliva and the possibility of microbial
proteases contributing to the observed degradation was not
investigated. To that end, this study intended to demonstrate that
C. albicans Saps are capable of degrading Hst-5 and to identify the
specific isoenzyme(s) responsible for the proteolysis.
In vitro assays designed to assess the integrity of Hst-5 following
exposure to C. albicans clearly demonstrated that C. albicans
rapidly degrades Hst-5 in as little as 20 minutes (Figure 2A). In
light of these findings and in order to attribute the degradation to
the Saps specifically, we conducted experiments using: (1) cell-
free supernatants of C. albicans suspensions in order to determine
whether the proteolytic substance is secreted or cell-associated (2)
specific protease inhibitors in order to determine the nature of
the proteolytic substance (3) purified proteases to confirm the
ability of the Saps to degrade Hst-5 in vitro and (4) SAP-deficient
mutants in order to identify the isoenzyme(s) responsible for the
degradation. The combined results from these experiments
demonstrated that the C. albicans-produced proteolytic substance
is cell-associated and aspartic in nature. The ability of the
purified Sap proteases to efficiently degrade Hst-5, further
implicated the Saps in the degradation of Hst-5. Interestingly,
since the C. albicans Sap9 and Sap10 proteases are considered to
be similar to the S. cerevisiase and C. glabrata yaspins, these species
were tested for their ability to degrade Hst-5. Results from these
experiments demonstrated that both S. cerevisiase and C. glabrata
exhibited significant enhanced degradation of Hst-5 compared to
C. albicans (Figure S2).
The availability of SAP-deficient mutants of C. albicans made it
possible to identify the Sap family isoenzyme(s) responsible for the
degradation of Hst-5. In these experiments, no visible differences
in levels of degradation were observed with the sap1–6 mutants
indicating that these secreted isoenzymes are not responsible for
the observed degradation under the conditions tested. In contrast,
complete loss of degradation was observed with the sap9 single
Figure 4. Minor inhibition of Hst-5 by the SAP10 deficient null mutant (sap10) and significant inhibition by the SAP9-deficient
mutant (sap9) and the SAP9 and SAP10 double mutant (sap9,10) compared to their parent strain (CAI4) and the C. albicans SC5314
(CA) strain.
doi:10.1371/journal.pone.0005039.g004
Figure 5. Separation of Hst-5 fragments by RP-HPLC following degradation by C. albicans resulting in 4 peaks corresponding to
fragments 18–24, 1–12, 1–17, and 1–24 on the Hst-5 amino acid sequence.
doi:10.1371/journal.pone.0005039.g005
Host Innate Immunity
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strain (Figure 4). These results directly implicated the Sap9
protease as the main isoenzyme responsible for the degradation of
Hst-5 by C. albicans cells, corroborating the previous indications
that the active proteolytic substance is cell-associated rather than
secreted. Furthermore, a recent study demonstrated that among
the SAP genes, SAP9 is the most highly and consistently expressed
gene during oral infections in vivo [28]. Combined these findings
seem to ascribe an important role for Sap9 in oral candidiasis, as
the increased expression of a proteolytic enzyme capable of
efficiently degrading Hst-5 may be a key event in the transition
from commensal to pathogenic growth or may further exacerbate
the infectious process.
In order to identify the cleavage sites for C. albicans cells and
purified proteases on Hst-5, peptide mapping was performed on
fragmentation products following degradation of Hst-5. Matrix-
assisted laser desorption/ionization mass spectrometry (MALDI-
TOF/TOF MS) analysis demonstrated that the degradation
profile generated by C. albicans, most closely resembled that of
the Sap9 protease (Figure 6). More importantly, four of the
identified cleavage sites were located within the 12-amino acid
antimicrobial fragment of Hst-5, implying that cleavage at these
sites would compromise the anti-candidal properties of Hst-5.
These implications were confirmed following evaluation of the
anti-candidal potency of Hst-5 following its degradation by C.
albicans cell and Sap9 and Sap10 purified proteases. Compared to
Figure 6. Comparison of cleavage fragments (1–4) identified by Mass Spectrometry following degradation of Hst-5 with C. albicans
whole cells and purified Sap9, Sap10 or Sap2 proteases. The boxed fragment in orange represents the part of the peptide with antimicrobial
properties. The green bars represent the fragments generated from cleavage within the antimicrobial fragment. The green bars boxed in red are the
1491.8 Da fragments generated by cleavage before Lys13 by C. albicans cells and Sap9. The blue bars represent the fragments generated only by Sap2
protease.
doi:10.1371/journal.pone.0005039.g006
Host Innate Immunity
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fragmented Hst-5 had no effect on C. albicans. These findings
clearly demonstrated that the ability of Hst-5 to kill C. albicans
largely depends on its integrity.
In principle, the lack of the ability of the sap9 mutant to degrade
Hst-5 may imply that this mutant would be more susceptible to
killing by Hst-5. Surprisingly, however, the mutant strain
demonstrated no statistically significant differences in susceptibility
to Hst-5 in vitro. The reasons are not clear, however, it is important
to note that we have recently shown that the sap9 and sap10
mutants have altered cell surfaces and modified susceptibilities to
antifungals [32]. Therefore, it is possible that the lack of enhanced
susceptibility of the mutants to Hst-5 maybe the result of the cell
surface modifications compensating for the lack of protease
degradation by the mutants.
Adherence of C. albicans to oral tissue is a pre-requisite for
colonization and proliferation leading to tissue invasion and
infection [39,40]. Candida albicans cell concentrations of 1610
2
cells/ml and below are indicative of commensal colonization in the
oral cavity [39]. In our experiments, this cell density was shown to
be susceptible and unable to degrade physiological concentrations
of Hst-5 in vitro. However, our results demonstrated that the level
of degradation of Hst-5 was proportional to the cell density of C.
albicans implying that the role Hst-5 plays in the oral cavity is
crucial in controlling the proliferation of commensal C. albicans
strains and in turn, the over-colonization of the oral mucosa by the
commensal strains.
It is interesting to note that the introduction of the HAART
anti-HIV therapy considerably reduced the incidence of oral
candidiasis [41]. This was not only attributed to the inhibition of
HIV protease essential for virus processing and proliferation and
therefore to an improved immunological status of a patient, but
also to a direct inhibition of C. albicans proteases responsible for
tissue invasion by the aspartic protease inhibitors part of the
HAART cocktail. In light of our new findings, however, the
observed protective effect of HAART may also be due to the direct
inhibition of Sap9 specifically, thus protecting histatin from
degradation and preserving its anti-candidal properties.
With the limited arsenal of antifungals available coupled with
the increasing emergence of resistant strains, the prospect of
preventing C. albicans colonization thus precluding candidiaisis by
using innate peptide antimicrobials as alternative drug therapies is
becoming increasingly attractive. Specifically, the anti-candidal
property coupled with its lack of toxicity to human cells, makes
Hst-5 a promising therapeutic agent for the treatment or
prevention of oral candidiasis in immunocompromised individuals.
However, in order to generate effective antimicrobial peptides, it is
important to identify the requirements for their intracellular
transport. In a recent study by Jang et al. [16], the substitution of
two lysine residues (Lys5 and Lys13) in Hst-5, resulted in inhibition
of Hst-5 intracellular transport into the fungal cell and in turn loss
of killing function. These findings are significant as they
demonstrate that translocation is dependent on the sequence of
the imported peptide [16]. Interestingly, a study by Ruissen et al.
[34] had reported that blocking cell entry of Hst-5 and several of
its peptide fragments greatly impeded their degradation by C.
albicans suggesting that proteolysis occurs mainly intracellularly
and is not used as a protective mechanism against Hst-5 activity.
In contrast, our study demonstrated that C. albicans Sap9 cleaves
Hst-5 at Lys13, the residue required for the successful intracellular
uptake of Hst-5. In light of these findings, and given the cell-
surface location of the Sap9, it is more likely that proteolysis of
Hst-5 by C. albicans occurs on the cell surface. Combined with the
killing assay results demonstrating loss of anti-candidal properties
of Hst-5 the result of its degradation by C. albicans, our findings
indicate that the proteolysis of Hst-5 by C. albicans constitutes a
self-defense strategy against host defenses in the oral cavity. The
dissemination of these new findings therefore, is crucial for the
design of novel peptides for therapeutic use for candidiasis and
specifically those peptides based on the structure of histatins,
which has been the focus of much research lately.
In summary, the novel findings from this investigation
demonstrate the ability of C. albicans to degrade the salivary anti-
candidal peptide Hst-5 in the process identifying Hst-5 as the first
host-specific substrate to C. albicans Sap9. These findings suggest
that Sap9 not only targets fungal-specific proteins, but also host
targets, specifically those involved in innate immune defenses.
Whereas the secreted members of the proteolytic enzymes are
known to be responsible for tissue penetration, in the oral cavity
the GPI-anchored proteases may pave the way to tissue invasion
by targeting the host substrate comprising the first line of defense
against invading pathogens. These findings warrant further in
depth investigations in order to determine the exact mechanism of
Hst-5 inactivation by C. albicans.
This report characterizes the first defined mechanism behind
the enhanced susceptibility of HIV+ individuals to oral candidiasis
since the emergence of HIV. The discussion and analysis
presented provide new insights characterizing a dynamic process
involving both host and pathogen factors behind the transition
from commensalism to parasitism that ultimately leads to the
development of oral candidiasis.
Materials and Methods
Reagents, strains, and growth conditions
The C. albicans SC5314 strain, the C. albicans SAP null mutants
sap1–3 triple mutant (lacking SAP1–3), sap4–6 triple mutant
(lacking SAP4–6), sap9 single mutant (lacking SAP9), sap10 single
mutant (lacking SAP10)a n dsap9,10 double mutant (lacking both
SAP9 and SAP10), as well as the parent strain CAI4 (URA-) were
used in these experiments [42,43,44]. Strains were grown in
YPD broth (Difco Laboratories, Detroit, MI) overnight at 30uC
with shaking and cells were equilibrated in fresh media to an
optical density of 1.0 at OD600. High purity Hst-5, proteinase K,
PMSF and pepstatin A were purchased from Sigma (Sigma-
Aldrich Chemical, St. Louis, MO). Histatin-5 was reconstituted
i n1m Mp h o s p h a t e - b u f f e r e ds a l i n e( P B S )a n du s e da taf i n a l
concentration of 150 mg/ml (within the range of physiological
salivary concentration) in all experiments unless otherwise stated.
All experiments were performed on at least three separate
occasions.
Sample preparation and degradation assay
Degradation assays were performed by incubating Hst-5 with
100 ml of standardized cell concentrations of the C. albicans strains
in PBS for 2 h at 37uC. Unless otherwise stated, C. albicans strains
were used in experiments at a cell concentration of 2610
8 cells/ml
(generating two visible bands). Protease K was used as a positive
control and negative controls with peptide and no C. albicans were
included. Following incubation, samples were collected, heated at
100uC to remove proteolytic activity and analyzed by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE).
Experiments were also performed using increasing C. albicans cell
densities and at different time points where samples were collected
following 20, 60 and 120 minutes incubation. In addition, assays
were performed using cell-free supernatants from C. albicans cell
suspensions to determine whether the proteolytic substance is
secreted.
Host Innate Immunity
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5039Densitometric analysis
The intensity of the bands on the Coomassie-stained gels was
assessed by densitometric analysis using a MultiImager scanner
(Bio-Rad Laboratories, Hercules California) and images analyzed
with the PDQuest version 7.0 (BioRAd).
Inhibition of degradation by protease inhibitors
Inhibition of degradation of Hst-5 by C. albicans cells was
determined using the degradation assay as described above in the
presence of 1 mM of the protease inhibitors pepstatin A and
PMSF (Sigma).
Degradation of Hst-5 by C. albicans purified proteases
The recombinant proteases Sap9 and Sap10 were produced in
Pichia pastoris as described previously [32,45]. Briefly, P. pastoris
strain GS115 was transformed with the expression plasmid
pKJ113 carrying truncated SAP9 and SAP10 versions lacking
signal peptide- and GPI anchor consensus- encoding sequences.
Proteases were recovered from culture supernatants and purified
via anion exchange chromatography. Activity of proteases was
verified by using a standard fluorescence casein based assay
(Molecular Probes). Purified proteases (0.05, 0.1, 0.25 and 0.5 mg)
were incubated with Hst-5 for 2 h. Following, samples were
processed as described above.
Peptide sequencing of degradation products by Matrix-
assisted laser desorption/ionization mass spectrometry
(MALDI-TOF MS)
Supernatants from the various degradation reactions were
subjected to peptide mapping in order to determine the sequences
of cleaved fragments, identify cleavage sites on the Hst-5 as well as
other cleavage products that may not be visible by electrophoresis.
Alternatively, fragments were first separated by RP-HPLC on a
1.06150 mm Microsorb 300 C18 column prior to sequencing in
order to reveal any other cleavage events that were refractory to
direct sequence analysis. Peptide samples were mixed with
saturated a-cyano-4-hydroxycinnamic acid in acetonitrile:trifluor-
oacetic acid 0.1% (1:2 v/v) then measured on an Ultraflex
MALDI-ToF/ToF device using flexControl 3.0 for data collection
and flexAnalysis 3.0 for spectra analysis and peaklist generation
(Bruker Daltonics GmbH, Germany). Suitable peptides of the
mass spectra were chosen for post source decay (PSD) MS
analyses. For data interpretation the MS peaklists were imported
into Biotools 3.0 (Bruker Daltonics) and compared to theoretical
fragments from in silico digests of Hst-5, assuming different
fragmentation mechanisms and taking into account missed
cleavages.
Histatin-5 killing assay
Candida albicans cells at various cell densities were mixed with
Hst-5 in the wells of a 96-well microtiter plate and incubated for
2 h at 37uC with shaking. Negative controls with cells and PBS
alone were included. Aliquots from reactions were inoculated on
YPD agar and incubated for 24–48 h at 35uC. The number of
single colonies on each plate was counted and percent cell killing
calculated.
The antimicrobial efficacy of Hst-5 following its degradation
was assessed where fragments liberated from degradation reactions
were used in killing assays as described above. Percent killing was
compared to that of intact Hst-5.
The ability of pepstatin A to maintain anti-candidal efficacy of
Hst-5 through inhibition of its degradation was assessed by
incorporating pepstatin A in the killing assays.
Killing assays were also performed following Hst-5 exposure to
Sap purified proteases and sap mutants.
Supporting Information
Figure S1 Degradation of Hst-5 by the Sap2 purified protease
(A) gel image demonstrating the ability of Sap2 protease to
degrade Hst-5 in a dose-dependent manner using 0.5 and 0.25 mg
(B) cleavage fragments identified by MS analysis.
Found at: doi:10.1371/journal.pone.0005039.s001 (0.33 MB TIF)
Figure S2 Degradation of Hst-5 by Candida glabrata (Cg) and
Saccharomyces cerevisiae (Sc) in comparison to C. albicans (CA). Both
species produce multiple (GPI)-linked aspartyl proteases, ortholo-
gues of the C. albicans Sap9 and Sap10 and, as shown, exhibit
significant enhanced degradation of Hst-5 compared to C. albicans.
Interestingly, Candida glabrata and Saccharomyces cerevisiae also
exhibited enhanced resistance to Hst-5. These findings corrobo-
rate those implicating the GPI-anchored proteases in C. albicans in
the degradation of Hst-5.
Found at: doi:10.1371/journal.pone.0005039.s002 (0.27 MB TIF)
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